The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID-19 pandemic.

Hithin NobleSyed Shariq HasanPeter J Whorwell Dipesh Harshvadan Vasant

Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2022)

This study has shown for the first time that patients seen in tertiary care with refractory IBS during the COVID-19 pandemic had a significantly higher symptom burden emphasizing the importance of gut-brain axis in IBS. Furthermore, lack of support and perceived loss of control appear to be contributory factors.

Keyphrases

irritable bowel syndrome
tertiary care
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
patient reported
physical activity
depressive symptoms
mental health
prognostic factors
social support
risk factors
resting state